⌕
Bioventus · BVS · Nasdaq
Tenet 56 · Mixed
Compare
$10.60+1.34%At closeTenet 56 · Mixed
$10.60+0.14 (+1.34%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Bioventus (BVS) Stock

Bioventus (BVS) closed at $10.60 on Nov 17, 2026; its Tenet Score is 56 of 100 against 340 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

11 figures withheld by our checks. Each blank figure names its reason.

Key stats

Close
$10.60
Nov 17, 2026
Market cap
$881.4M
share price × the latest quarter's diluted weighted-average share count (vendor)
52-week range
6.47 – 15.89
low → high · as of close, Nov 16, 2026
Tenet Score
56/100
Mixed · 340 Healthcare peers

Industry: Specialty Retail

Bioventus Inc scores 56/100. Mixed. Strongest on value and quality, financial health is the soft spot versus 340 Healthcare peers.

Tenet Score · vs sector

n=340
56/ 100
Mixed
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
72
Quality
65
Health
28
Growth
60

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueBQualityCHealthFGrowthCMomentumA
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Withheld: our recalculation of this figure from its inputs did not match the reported value.
P/B
3.7×
Sep 26, 2026 balance sheet
P/S
1.5×
price to sales, TTM through Sep 26, 2026 · as of close, Nov 16, 2026
ROE
23%
TTM through Sep 26, 2026
Operating margin
9.5%
fiscal 2025, before interest and tax
Net margin
9.8%
TTM through Sep 26, 2026
Current ratio
1.68
Sep 26, 2026 balance sheet
Net debt / EBITDA
2.0×
TTM through Sep 26, 2026
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Bioventus Inc

Bioventus Inc. a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's portfolio of products includes pain t…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=340) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 64 US ETFs · top wrappers by weightSee all ETFs holding BVS →

Similar-sized companies in Specialty Retail

The 10 companies in this industry closest in market cap, as of Nov 16, 2026.

What sector and industry is Bioventus in?

Bioventus is in the Healthcare sector and the Specialty Retail industry.

What is Bioventus' Tenet Score?

Bioventus' Tenet Score is 56 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.